| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/11/2001 | EP0683783B1 Rapamycin derivative process for its preparation and its use |
| 07/11/2001 | EP0660837B1 Penem derivatives, their preparation and pharmaceutical compositions containing them |
| 07/11/2001 | CN1303394A Peptide compound for preventing and treating HIV infection and immunity diseases |
| 07/11/2001 | CN1303390A Novel crystalline forms for antiviral benzimidazole compound |
| 07/11/2001 | CN1303378A 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for treatment of HIV related diseases |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1303279A Topical transdermal treatments |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1302662A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302656A Veterinary medicine prepared from sophora seed and its preparing process |
| 07/11/2001 | CN1302652A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302651A Oral immune using plant product containing hepatitis surface antigen |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302642A Chinese medicine for treating tuberculosis and hepatitis |
| 07/11/2001 | CN1302638A Anti-infection Chinese medicine for clearing heat and detoxicating and its preparing process |
| 07/11/2001 | CN1302637A Medicinal material resisting against human cytomegalovirus and its application in preparing medicines |
| 07/11/2001 | CN1302634A Medicine for curing metritis |
| 07/11/2001 | CN1302612A Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 07/11/2001 | CN1302611A Veterinary medicine for treating diseases caused by bacteria and mycoplasma infections |
| 07/11/2001 | CN1068328C Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 07/11/2001 | CN1068325C Phenyloxazolidinone antimicrobials |
| 07/11/2001 | CN1068227C Interferon liposome jellies |
| 07/11/2001 | CN1068226C Venereal disease preventing medicine containing interferon |
| 07/11/2001 | CN1068209C Chinese patent medicine for curing tuberculosis of lung and preparation process thereof |
| 07/10/2001 | US6258952 Thermally stable trimetrexates and processes for producing the same |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258945 HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258936 SpoIIIE |
| 07/10/2001 | US6258932 Tripeptide of defined amino acid sequence and having a c-terminal amide; viricides; treatment and prevention of human immunodeficiency virus |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258831 Viral treatment |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |
| 07/10/2001 | US6258797 Combating infection in delivery systems |
| 07/10/2001 | US6258789 Delivery of gene products by intestinal cell expression |
| 07/10/2001 | US6258788 Induction of protective immune response to tick borne flavivirus proteins |
| 07/10/2001 | US6258782 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/10/2001 | US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 07/10/2001 | US6258774 Carrier for in vivo delivery of a therapeutic agent |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258599 Compositions and methods for treating viral infections |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258374 Rectal or vaginal administration; polymer stabilizer; water soluble foam structure |
| 07/10/2001 | US6258372 Xylitol nose spray |
| 07/10/2001 | US6258362 Genetically attenuated; vaccine contains polysaccharide and/or amino acid source, buffer, and monosaccharide, oligosaccharide, or sugar alcohol |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/10/2001 | CA2139653C Optically pure salts of pyridinylmethyl sulfinyl-ih- benzimidazole compounds |
| 07/10/2001 | CA2032505C Coat transmembrane glycoprotein antigens of a hiv-2 type human retrovirus and antigens sharing immunological similarities |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/05/2001 | WO2001048248A2 High throughput screen for inhibitors of fatty acid biosynthesis in bacteria |
| 07/05/2001 | WO2001048209A2 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | WO2001048208A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | WO2001048117A1 Dry compositions containing hydrophobic amino acid |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047962A2 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | WO2001047961A1 P. gingivalis antigenic composition |
| 07/05/2001 | WO2001047955A2 Improvements in or relating to immune responses to hiv |
| 07/05/2001 | WO2001047948A1 Novel dipeptide compound and medicinal use thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047930A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047904A1 Thiazolyl amide derivatives |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047883A1 Fused-ring compounds and use thereof as drugs |
| 07/05/2001 | WO2001047881A1 Ascosalipyrrolone derivatives |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047562A2 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 07/05/2001 | WO2001047551A2 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 07/05/2001 | WO2001047550A1 Method for treatment of canine distemper |
| 07/05/2001 | WO2001047545A1 Preventives and remedies for chronic hepatitis |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047511A2 Treatment of drug-resistant human immunodeficiency virus infection |
| 07/05/2001 | WO2001047499A1 Pharmaceutical formulations comprising sodium amoxycillin and potassium clavulanate |
| 07/05/2001 | WO2001047492A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001000554A3 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
| 07/05/2001 | WO2000078745A3 Crystalline form of (r)-2-[[[3-methyl- 4- (2,2,2,- trifluoroethoxy) -2- pyridinyl] methyl] sulfinyl] -1h-benzimidazole |
| 07/05/2001 | WO2000078343A3 Method for treating chronic hbv infection |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000064903A3 Methods for preparing antiviral calanolide compounds |
| 07/05/2001 | WO2000055621A8 Blood leucocyte apheresis for treatment of disease |
| 07/05/2001 | WO2000052134A3 Inhibitors of prenyl-protein transferase |
| 07/05/2001 | WO2000035945A8 Cyclic peptide antifungal agents having a sugar substituent |
| 07/05/2001 | WO2000023114A9 Polymer conjugates of interferon beta- 1a and their uses |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | US20010007022 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free N-procalcitonin; used as an in vitro or in vivo diagnostic agent |